Latest News

eye on pharma banner
Eye on Pharma: BI Cyltezo Partnership; Europe Ustekinumab Launch; Mexico Biosimilar Approval

July 24th 2024

Boehringer Ingelheim (BI) partners with GoodRx to offer Cyltezo, an adalimumab biosimilar, to patients; a new ustekinumab biosimilar launches in Europe; and Mexican officials approve a bevacizumab biosimilar.

Eye on Pharma banner
Eye on Pharma: New Data, Clinical Developments, and Biosimilar Partnerships

July 4th 2024

syringe and money | Image credit: -
Review Finds 7 Themes That Can Help Define the Value of Biosimilars

June 10th 2024

Biosimilars Check-In banner
Biosimilars Check-In: Application Acceptances, European Approvals, New Partnerships

June 6th 2024

Eye on Pharma banner
Eye on Pharma: Simlandi US Launch; Ranibizumab Partnership; Expanded Access for Adalimumab Biosimilars

May 27th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.